In human models, studies have suggested that CXCR4 expression could correlate with human epidermal growth factor receptor (HER)-2 expression in breast cancer patients (30), and could be associated with the development of lung metastases (30), liver metastases (31), or bone marrow micrometastases (32, 33) in breast cancer. This evidence concerns the gene ERBB2 and breast cancer.